Abstract:The enzyme complex IB kinase (IKK) is an essential activator of NF-B signaling pathway involved in propagating the cellular response to inflammation. The complex contains two functional subunits IKK and IKK, which are structurally conserved kinases and selective inhibition of them would result in distinct biological effects. However, most existing IKK inhibitors show moderate or high promiscuity for the two homologous kinases. Understanding of the molecular mechanism and biological implication underlying the specific interactions in IKK-ligand recognition is thus fundamentally important for the rational design of selective IKK inhibitors. In the current work, we integrated molecular docking, quantum mechanics/molecular mechanics calculation and Poisson-Boltzmann/surface area analysis to investigate the structural basis and energetic property of the selective binding of small-molecule ligands to IKK and IKK. It was found that the selectivity is primarily determined by the size and topology difference in ATP-binding pocket of IKK and IKK kinase domains; bulky inhibitor molecules commonly have, respectively, low and appropriate affinities towards IKK and IKK, and thus exhibit relatively high selectivity for IKK over IKK, whereas small ligands can only bind weakly to both the two kinases with low selectivity. In addition, the conformation, arrangement and distribution of residues in IKK pockets are also responsible for constituting the exquisite specificity of ligand binding to KK and IKK. Next, a novel quantitative structure-selectivity relationship model was developed to characterize the relative contribution of each kinase residue to inhibitor selectivity and to predict the selectivity and specificity for a number of known IKK inhibitors. Results showed that the active-site residues contribute significantly to the selectivity by directly interacting with inhibitor ligands, while those protein portions far away from the kinase active sites may also play an important role in determining the selectivity through long-range non-bonded forces and indirect allosteric effect.

Crystal Structure of Inhibitor of Kappa B Kinase Beta

Crystal structure of inhibitorof k Bkinase b

Structure and Ubiquitination-Dependent Activation of Tank-Binding Kinase 1

Crystal structure of the ubiquitin-like domain of human TBK1

Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates

Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation

The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.

IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors

Novel IKKβ Inhibitors Discovery Based on the Co-Crystal Structure by Using Binding-Conformation-based and Ligand-Based Method.

Insight Into The Intermolecular Recognition Mechanism Between Keap1 And Ikk Beta Combining Homology Modelling, Protein-Protein Docking, Molecular Dynamics Simulations And Virtual Alanine Mutation

The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region

A Novel Allosteric Inhibitor That Prevents IKKβ Activation.

Structural Insights into the Functions of Tbk1 in Innate Antimicrobial Immunity

Cryo-EM structures of PI3K reveal conformational changes during inhibition and activation

The Crystal Structure of an Inactive Dimer of PDZ-binding Kinase

Activation of the Heterodimeric Ikappa B Kinase alpha (IKKalpha )-IKKbeta Complex Is Directional: IKKalpha Regulates IKKbeta under Both Basal and Stimulated Conditions

Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.

[Research Progress of the Biological Characteristics of IkappaB Kinase and Its Inhibitors].

Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions

Crystal Structures of the Kinase Domain of PpkA, a Key Regulatory Component of T6SS, Reveal a General Inhibitory Mechanism.